Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Main Capital and Pointsharp in its strategic merger with SIVIS
Mandate

Vinge has advised Main Capital and Pointsharp in its strategic merger with SIVIS

August 10, 2023 M&A Corporate Tax

Pointsharp enables organizations to secure IT environments with a high level of control for IT departments combined with an intuitive mobile user experience.

Pointsharp has a broad solution offering in the identity and access management market related to multi-factor authentication, secure access, user provisioning and password management. SIVIS, founded in 1999 and having its base in Germany and Denmark, focuses on areas such as identity and access management and risk management.

The addition of SIVIS’ strong offering within identity and role management is expected to strengthen the combined group's position.

Vinge's team consisted of Filip Öhrner, Linus Adolfsson and Josef Groow.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025